tirzepatide osa fda approval Huge news: has approved Zepbound (tirzepatide- GLP-1/GIP receptor agonist) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. As a cardiologist, this is a huge deal tirzepatide sleep apnea fda approval
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27






:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)

















